Cymbalta sales catalyst for Lilly's overall sales

Share this article:
Lilly credited increased Cymbalta sales for a 7% gain in overall sales for the 3rd Quarter, and said marketing and administrative costs were up 12%, due to increased advertising and promotion for the brand.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.